$LDWY
LENDWAY, INC. Stock $ldwy

$ldwy Overview Financials Valuation SEC Filings Company Website

2021 Q4 Form 10-K Financial Statement

#000165495422002804 Filed on March 09, 2022

Income Statement

Concept	2021 Q4	2021	2020 Q4
Revenue	$4.528M	$19.50M	$5.110M
YoY Change	-11.39%	11.56%	-19.15%
Cost Of Revenue	$3.980M	$0.00	$4.020M
YoY Change	-1.0%	-100.0%	-14.83%
Gross Profit	$548.0K	$3.230M	$1.090M
YoY Change	-49.72%	13.1%	-31.88%
Gross Profit Margin	12.1%	16.56%	21.33%
Selling, General & Admin	$1.802M	$8.021M	$2.010M
YoY Change	-10.35%	1.66%	-5.19%
% of Gross Profit	328.83%	248.33%	184.4%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$14.00K	$60.00K	$90.00K
YoY Change	-84.44%	-87.42%	-80.43%
% of Gross Profit	2.55%	1.86%	8.26%
Operating Expenses	$1.802M	$8.021M	$2.010M
YoY Change	-10.35%	4.24%	-5.63%
Operating Profit	-$1.254M	-$4.791M	-$920.0K
YoY Change	36.3%	-0.99%	73.58%
Interest Expense	-$1.289M	-$1.335M
YoY Change
% of Operating Profit
Other Income/Expense, Net	$1.571M	$0.00	$60.00K
YoY Change	2518.33%	-100.0%	100.0%
Pretax Income	-$972.0K	$273.0K	-$860.0K
YoY Change	13.02%		-65.74%
Income Tax	$10.00K	$42.00K	$10.00K
% Of Pretax Income		15.38%
Net Earnings	-$982.0K	-$3.534M	-$870.0K
YoY Change	12.87%	-23.42%	-64.63%
Net Earnings / Revenue	-21.69%	-18.12%	-17.03%
Basic Earnings Per Share		-$2.01
Diluted Earnings Per Share	-$555.1K	-$2.01	-$497.1K
COMMON SHARES
Basic Shares Outstanding	1.768M shares	1.760M shares
Diluted Shares Outstanding		1.760M shares

Balance Sheet

Concept	2021 Q4	2021	2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$3.766M	$3.766M	$7.130M
YoY Change	-47.18%	-47.18%	-5.06%
Cash & Equivalents	$3.851M	$3.766M	$7.128M
Short-Term Investments
Other Short-Term Assets	$1.318M	$1.318M	$710.0K
YoY Change	85.63%	85.63%	86.84%
Inventory	$19.00K	$19.00K	$85.00K
Prepaid Expenses
Receivables	$5.247M	$5.247M	$5.857M
Other Receivables	$4.000K	$4.000K	$240.0K
Total Short-Term Assets	$10.35M	$10.35M	$14.02M
YoY Change	-26.16%	-24.92%	-11.76%
LONG-TERM ASSETS
Property, Plant & Equipment	$113.0K	$296.0K	$75.00K
YoY Change	50.67%	169.09%	-89.73%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$0.00	$0.00	$155.0K
YoY Change	-100.0%	-100.0%	-58.11%
Total Long-Term Assets	$296.0K	$296.0K	$267.0K
YoY Change	10.86%	9.63%	-75.73%
TOTAL ASSETS
Total Short-Term Assets	$10.35M	$10.35M	$14.02M
Total Long-Term Assets	$296.0K	$296.0K	$267.0K
Total Assets	$10.65M	$10.65M	$14.29M
YoY Change	-25.47%	-24.25%	-15.9%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.539M	$2.539M	$3.148M
YoY Change	-19.35%	-19.4%	3.55%
Accrued Expenses	$3.257M	$3.257M	$1.310M
YoY Change	148.63%	148.63%	-0.76%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$0.00	$0.00	$464.0K
YoY Change	-100.0%	-100.0%
Total Short-Term Liabilities	$6.638M	$6.638M	$6.354M
YoY Change	4.47%	30.16%	41.2%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$590.0K
YoY Change	-100.0%	-100.0%
Other Long-Term Liabilities	$819.0K	$819.0K	$680.0K
YoY Change	20.44%	20.44%	-2.86%
Total Long-Term Liabilities	$819.0K	$819.0K	$1.267M
YoY Change	-35.36%	-35.51%	81.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$6.638M	$6.638M	$6.354M
Total Long-Term Liabilities	$819.0K	$819.0K	$1.267M
Total Liabilities	$7.457M	$7.457M	$7.621M
YoY Change	-2.15%	17.06%	46.56%
SHAREHOLDERS EQUITY
Retained Earnings	-$13.12M		-$9.587M
YoY Change	36.86%
Common Stock	$18.00K		$17.00K
YoY Change	5.88%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$3.193M	$3.193M	$6.668M
YoY Change
Total Liabilities & Shareholders Equity	$10.65M	$10.65M	$14.29M
YoY Change	-25.47%	-24.25%	-15.9%

Cashflow Statement

Concept	2021 Q4	2021	2020 Q4
OPERATING ACTIVITIES
Net Income	-$982.0K	-$3.534M	-$870.0K
YoY Change	12.87%	-23.42%	-64.63%
Depreciation, Depletion And Amortization	$14.00K	$60.00K	$90.00K
YoY Change	-84.44%	-87.42%	-80.43%
Cash From Operating Activities	$323.0K	-$3.000M	$70.00K
YoY Change	361.43%	89.87%	-130.43%
INVESTING ACTIVITIES
Capital Expenditures	-$25.00K	$106.0K	$0.00
YoY Change		73.77%	-100.0%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$16.00K	$0.00
YoY Change		-92.0%
Cash From Investing Activities	-$25.00K	-$90.00K	$0.00
YoY Change		-164.75%	-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$27.00K
YoY Change		35.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-181.0K	-$187.0K	0.000
YoY Change		-117.66%
NET CHANGE
Cash From Operating Activities	323.0K	-$3.000M	70.00K
Cash From Investing Activities	-25.00K	-$90.00K	0.000
Cash From Financing Activities	-181.0K	-$187.0K	0.000
Net Change In Cash	117.0K	-$3.277M	70.00K
YoY Change	67.14%	757.85%	-125.93%
FREE CASH FLOW
Cash From Operating Activities	$323.0K	-$3.000M	$70.00K
Capital Expenditures	-$25.00K	$106.0K	$0.00
Free Cash Flow	$348.0K	-$3.106M	$70.00K
YoY Change	397.14%	89.27%	-136.84%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	366000	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	335000	USD
CY2021Q4	us-gaap	Assets Current AssetsCurrent	10354000	USD
CY2021	dei	Auditor Location AuditorLocation	Minneapolis, Minnesota
CY2021Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	3766000	USD
CY2020Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	7128000	USD
CY2021Q4	us-gaap	Restricted Cash And Investments Current RestrictedCashAndInvestmentsCurrent	85000	USD
CY2020Q4	us-gaap	Restricted Cash And Investments Current RestrictedCashAndInvestmentsCurrent	0	USD
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	5247000	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	5857000	USD
CY2021Q4	us-gaap	Inventory Net InventoryNet	19000	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	85000	USD
CY2021Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	4000	USD
CY2020Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	241000	USD
CY2021Q4	us-gaap	Deferred Offering Costs DeferredOfferingCosts	867000	USD
CY2020Q4	us-gaap	Deferred Offering Costs DeferredOfferingCosts	376000	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	14022000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	113000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	75000	USD
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	183000	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	37000	USD
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	0	USD
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	155000	USD
CY2021Q4	us-gaap	Assets Assets	10650000	USD
CY2020Q4	us-gaap	Assets Assets	14289000	USD
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2539000	USD
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	3148000	USD
CY2021Q4	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	464000	USD
CY2020Q4	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	424000	USD
CY2021Q4	isig	Sales Tax SalesTax	1287000	USD
CY2020Q4	isig	Sales Tax SalesTax	1011000	USD
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1430000	USD
CY2020Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1071000	USD
CY2021Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	0	USD
CY2020Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	464000	USD
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	76000	USD
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	56000	USD
CY2021Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	842000	USD
CY2020Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	180000	USD
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	6638000	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	6354000	USD
CY2021Q4	us-gaap	Liability For Uncertain Tax Positions Noncurrent LiabilityForUncertainTaxPositionsNoncurrent	711000	USD
CY2020Q4	us-gaap	Liability For Uncertain Tax Positions Noncurrent LiabilityForUncertainTaxPositionsNoncurrent	677000	USD
CY2021Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	0	USD
CY2020Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	590000	USD
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	108000	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	0	USD
CY2021Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	819000	USD
CY2020Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	1267000	USD
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	USD
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	18000	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	17000	USD
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	16296000	USD
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	16238000	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-13121000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-9587000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	3193000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	6668000	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	10650000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	14289000	USD
CY2021	isig	Services Revenues ServicesRevenues	19503000	USD
CY2020	isig	Services Revenues ServicesRevenues	16904000	USD
CY2021	isig	Products Revenues ProductsRevenues	0	USD
CY2020	isig	Products Revenues ProductsRevenues	578000	USD
CY2021	us-gaap	Revenues Revenues	19503000	USD
CY2020	us-gaap	Revenues Revenues	17482000	USD
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	16273000	USD
CY2020	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	13934000	USD
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	0	USD
CY2020	us-gaap	Cost Of Revenue CostOfRevenue	533000	USD
CY2021	us-gaap	Impairment Of Investments ImpairmentOfInvestments	0	USD
CY2020	us-gaap	Impairment Of Investments ImpairmentOfInvestments	159000	USD
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	16273000	USD
CY2021	us-gaap	Gross Profit GrossProfit	3230000	USD
CY2020	us-gaap	Gross Profit GrossProfit	2856000	USD
CY2021	us-gaap	Selling Expense SellingExpense	1931000	USD
CY2020	us-gaap	Selling Expense SellingExpense	2877000	USD
CY2021	us-gaap	Marketing Expense MarketingExpense	1032000	USD
CY2020	us-gaap	Marketing Expense MarketingExpense	1015000	USD
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5058000	USD
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3998000	USD
CY2021	us-gaap	Disposal Group Not Discontinued Operation Gain Loss On Disposal DisposalGroupNotDiscontinuedOperationGainLossOnDisposal	0	USD
CY2020	us-gaap	Disposal Group Not Discontinued Operation Gain Loss On Disposal DisposalGroupNotDiscontinuedOperationGainLossOnDisposal	195000	USD
CY2021	us-gaap	Operating Expenses OperatingExpenses	8021000	USD
CY2020	us-gaap	Operating Expenses OperatingExpenses	7695000	USD
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-4791000	USD
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-4839000	USD
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-1062000	USD
CY2020	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	273000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	0	USD
CY2021	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-36000	USD
CY2020	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-32000	USD
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	0	USD
CY2020	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	65000	USD
CY2021	us-gaap	Other Income OtherIncome	1299000	USD
CY2020	us-gaap	Other Income OtherIncome	33000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-3492000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-4806000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	42000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-191000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-3534000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-4615000	USD
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.01
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-3534000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-4615000	USD
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.66
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.01
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.66
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1760000	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1734000	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1760000	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1734000	shares
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	11083000	USD
CY2020	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	20000	USD
CY2020	isig	Vesting Of Restricted Stock Units Offset By Repurchase Of Common Stock Upon Vesting Of Restricted Stock Units And Awards Amount VestingOfRestrictedStockUnitsOffsetByRepurchaseOfCommonStockUponVestingOfRestrictedStockUnitsAndAwardsAmount	-1000	USD
CY2020	isig	Valueofstockbasedcompensation Shares ValueofstockbasedcompensationShares	172000	USD
CY2020	isig	Common Stock Issued For Accrued Liabilities Shares CommonStockIssuedForAccruedLiabilitiesShares	9000	USD
CY2020	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-4615000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	6668000	USD
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	27000	USD
CY2021	isig	Repurchase Of Common Stock Upon Vesting Of Restricted Stock Units Amount RepurchaseOfCommonStockUponVestingOfRestrictedStockUnitsAmount	-200000	USD
CY2021	isig	Valueofstockbasedcompensation Shares ValueofstockbasedcompensationShares	232000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-3534000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	3193000	USD
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	60000	USD
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	477000	USD
CY2021	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
CY2020	us-gaap	Asset Impairment Charges AssetImpairmentCharges	159000	USD
CY2021	us-gaap	Disposal Group Not Discontinued Operation Gain Loss On Disposal DisposalGroupNotDiscontinuedOperationGainLossOnDisposal	0	USD
CY2020	us-gaap	Disposal Group Not Discontinued Operation Gain Loss On Disposal DisposalGroupNotDiscontinuedOperationGainLossOnDisposal	195000	USD
CY2021	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-6000	USD
CY2020	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	35000	USD
CY2021	us-gaap	Allowance For Doubtful Accounts Receivable Period Increase Decrease AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease	87000	USD
CY2020	us-gaap	Allowance For Doubtful Accounts Receivable Period Increase Decrease AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease	203000	USD
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	232000	USD
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	172000	USD
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-1062000	USD
CY2020	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	523000	USD
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1679000	USD
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	66000	USD
CY2020	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	135000	USD
CY2021	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	237000	USD
CY2020	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-115000	USD
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-392000	USD
CY2020	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-327000	USD
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-572000	USD
CY2020	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	115000	USD
CY2021	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	665000	USD
CY2020	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	623000	USD
CY2021	isig	Increase Decrease In Accrued Income Taxes IncreaseDecreaseInAccruedIncomeTaxes	34000	USD
CY2020	isig	Increase Decrease In Accrued Income Taxes IncreaseDecreaseInAccruedIncomeTaxes	34000	USD
CY2021	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	662000	USD
CY2020	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	40000	USD
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3000000	USD
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1580000	USD
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	106000	USD
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	61000	USD
CY2021	isig	Proceeds From Sale Of Custom Print Business ProceedsFromSaleOfCustomPrintBusiness	0	USD
CY2020	isig	Proceeds From Sale Of Custom Print Business ProceedsFromSaleOfCustomPrintBusiness	-200000	USD
CY2021	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	16000	USD
CY2020	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	USD
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-90000	USD
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	139000	USD
CY2021	isig	Cash Dividends Paid CashDividendsPaid	-14000	USD
CY2020	isig	Cash Dividends Paid CashDividendsPaid	-14000	USD
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	27000	USD
CY2020	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	20000	USD
CY2021	us-gaap	Payments For Repurchase Of Other Equity PaymentsForRepurchaseOfOtherEquity	200000	USD
CY2020	us-gaap	Payments For Repurchase Of Other Equity PaymentsForRepurchaseOfOtherEquity	1000	USD
CY2021	us-gaap	Proceeds From Loan Originations1 ProceedsFromLoanOriginations1	0	USD
CY2020	us-gaap	Proceeds From Loan Originations1 ProceedsFromLoanOriginations1	1054000	USD
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-187000	USD
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1059000	USD
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-3277000	USD
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-382000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7510000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3851000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7128000	USD
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	230000	USD
CY2020	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-112000	USD
CY2021	us-gaap	Other Significant Noncash Transaction Value Of Consideration Given1 OtherSignificantNoncashTransactionValueOfConsiderationGiven1	13000	USD
CY2020	us-gaap	Other Significant Noncash Transaction Value Of Consideration Given1 OtherSignificantNoncashTransactionValueOfConsiderationGiven1	11000	USD
CY2021	isig	Common Stock Issued For Accrued Liabilities CommonStockIssuedForAccruedLiabilities	0	USD
CY2020	isig	Common Stock Issued For Accrued Liabilities CommonStockIssuedForAccruedLiabilities	9000	USD
CY2021	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	0	USD
CY2020	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	100000	USD
CY2021	us-gaap	Proceeds From Sale Of Other Property Plant And Equipment ProceedsFromSaleOfOtherPropertyPlantAndEquipment	0	USD
CY2020	us-gaap	Proceeds From Sale Of Other Property Plant And Equipment ProceedsFromSaleOfOtherPropertyPlantAndEquipment	195000	USD
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	219000	USD
CY2020	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	USD
CY2021	us-gaap	Nature Of Operations NatureOfOperations	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"><strong><em>Description of Business</em></strong><em>.<strong> </strong></em>Insignia (the “Company”) is a leading provider of in-store solutions to consumer-packaged goods (“CPG”) manufacturers, retailers, shopper marketing agencies and brokerages. The Company operates in a single reportable segment. The Company’s leadership and employees have extensive industry knowledge with direct experience in both CPG manufacturers and retailers. The Company provides marketing solutions to CPG manufacturers spanning from some of the largest multinationals to new and emerging brands. The Company’s primary solutions are merchandising solutions, on-pack solutions and signage.</p>
CY2020Q3	isig	Sale Of Custom Print Business SaleOfCustomPrintBusiness	300000	USD
CY2020Q3	us-gaap	Disposal Group Not Discontinued Operation Gain Loss On Disposal DisposalGroupNotDiscontinuedOperationGainLossOnDisposal	195000	USD
CY2020Q3	us-gaap	Proceeds From Sale And Collection Of Receivables ProceedsFromSaleAndCollectionOfReceivables	200000	USD
CY2020Q3	isig	Increase Decrease In Short Term Receivables IncreaseDecreaseInShortTermReceivables	75000	USD
CY2020Q3	isig	Increase Decrease In Long Term Receivables IncreaseDecreaseInLongTermReceivables	25000	USD
CY2021Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	25000	USD
CY2021Q4	isig	Cash Invested In Insured Cash Sweep Account CashInvestedInInsuredCashSweepAccount	3849000	USD
CY2020Q4	isig	Cash Invested In Insured Cash Sweep Account CashInvestedInInsuredCashSweepAccount	7113000	USD
CY2021	isig	Restricted Cashpolicytextblock RestrictedCashpolicytextblock	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"><strong><em>Restricted Cash. </em></strong>The Company’s restricted cash consists of cash the Company is contractually obligated to maintain in accordance with the terms of its lease signed in April 2021 for its headquarters space in Minneapolis. See Note 4 for further discussion.</p>
CY2021Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	0	USD
CY2020Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	268000	USD
CY2019Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	65000	USD
CY2021	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	71000	USD
CY2020	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	203000	USD
CY2021	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	111000	USD
CY2020	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	0	USD
CY2021	us-gaap	Financing Receivable Allowance For Credit Losses Recovery FinancingReceivableAllowanceForCreditLossesRecovery	95000	USD
CY2020	us-gaap	Financing Receivable Allowance For Credit Losses Recovery FinancingReceivableAllowanceForCreditLossesRecovery	0	USD
CY2021Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	355000	USD
CY2020Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	268000	USD
CY2021Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	0	USD
CY2020Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	32000	USD
CY2020Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	2000	USD
CY2020Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	19000	USD
CY2021Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	51000	USD
CY2021Q4	us-gaap	Inventory Net InventoryNet	19000	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	85000	USD
CY2021	isig	Schedule Of Property And Equipmenttabletextblock ScheduleOfPropertyAndEquipmenttabletextblock	<table cellpadding="0" style="border-spacing:0;font-size:10pt;text-align:justify;margin-left:auto;margin-right:auto;width:92%"><tbody><tr style="height:15px;background-color:#cceeff"><td style="width:80%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Production tooling, machinery and equipment</p></td><td style="width:19%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">1 – 6 years</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:80%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Office furniture and fixtures</p></td><td style="width:19%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">1 – 3 years</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:80%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Computer equipment and software</p></td><td style="width:19%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">3 – 5 years</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:80%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Leasehold improvements</p></td><td style="width:19%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">1 –3 years</p></td></tr></tbody></table>
CY2021Q4	isig	Reduce Workforce Percent ReduceWorkforcePercent	0.19	pure
CY2011	isig	Term Of Agreement TermOfAgreement	P10Y
CY2021Q1	isig	Asset Impairment Charge AssetImpairmentCharge	159000	USD
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	158000	USD
CY2021Q4	us-gaap	Restructuring Charges RestructuringCharges	201000	USD
CY2021	us-gaap	Restructuring Charges RestructuringCharges	201000	USD
CY2021	us-gaap	Advertising Expense AdvertisingExpense	34000	USD
CY2020	us-gaap	Advertising Expense AdvertisingExpense	69000	USD
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1734000	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1760000	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1734000	shares
CY2021	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2020	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1760000	shares
CY2021Q3	us-gaap	Reinsurance Retention Policy Amount Retained ReinsuranceRetentionPolicyAmountRetained	293000	USD
CY2021Q3	us-gaap	Reinsurance Retention Policy Amount Retained ReinsuranceRetentionPolicyAmountRetained	293000	USD
CY2021Q3	isig	Benefits Reduced Due To Filling And Preparation Costs BenefitsReducedDueToFillingAndPreparationCosts	20000	USD
CY2021Q3	isig	Net Benefit After Deducting Filling And Preparation Costs NetBenefitAfterDeductingFillingAndPreparationCosts	273000	USD
CY2021	us-gaap	Use Of Estimates UseOfEstimates	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"><strong><em>Use of Estimates</em></strong>. The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from these estimates.</p>
CY2021	us-gaap	Revenues Revenues	19503000	USD
CY2020	us-gaap	Revenues Revenues	17482000	USD
CY2020Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	180000	USD
CY2021	isig	Reclassification Of Deferred Revenue ReclassificationOfDeferredRevenue	-180000	USD
CY2021	isig	Cash Received In Advance Not Recognized As Revenue CashReceivedInAdvanceNotRecognizedAsRevenue	842000	USD
CY2021Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	842000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	898000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	4238000	USD
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	785000	USD
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	4163000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	113000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	75000	USD
CY2021	us-gaap	Depreciation Depreciation	60000	USD
CY2020	us-gaap	Depreciation Depreciation	314000	USD
CY2020Q4	isig	Net Book Value Of Property Plant And Equipment NetBookValueOfPropertyPlantAndEquipment	230000	USD
CY2020	us-gaap	Proceeds From Sale Of Other Property Plant And Equipment ProceedsFromSaleOfOtherPropertyPlantAndEquipment	195000	USD
CY2020	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-35000	USD
CY2021Q4	us-gaap	Restricted Cash RestrictedCash	85000	USD
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.048	pure
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P1Y
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	79000	USD
CY2021	us-gaap	Variable Lease Cost VariableLeaseCost	52000	USD
CY2021	us-gaap	Short Term Lease Cost ShortTermLeaseCost	28000	USD
CY2021	us-gaap	Lease Cost LeaseCost	159000	USD
CY2020	us-gaap	Operating Lease Cost OperatingLeaseCost	150000	USD
CY2020	us-gaap	Variable Lease Cost VariableLeaseCost	104000	USD
CY2020	us-gaap	Short Term Lease Cost ShortTermLeaseCost	40000	USD
CY2020	us-gaap	Lease Cost LeaseCost	294000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Rolling Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths	83000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due In Rolling Year Two LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo	72000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due In Rolling Year Three LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree	40000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	195000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	11000	USD
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	184000	USD
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	97000	USD
CY2020	us-gaap	Operating Lease Payments OperatingLeasePayments	222000	USD
CY2021	isig	Increase In Operating Lease Liabilities And Right Of Use IncreaseInOperatingLeaseLiabilitiesAndRightOfUse	219000	USD
CY2021	isig	Fixed And Storebased Payments FixedAndStorebasedPayments	199000	USD
CY2020	isig	Fixed And Storebased Payments FixedAndStorebasedPayments	2765000	USD
CY2021Q4	us-gaap	Purchase Obligation PurchaseObligation	50000	USD
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	232000	USD
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	172000	USD
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.001	pure
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.016	pure
CY2020	isig	Share Based Compensation Arrangement By Share Based Payment Award Number Of Granted Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfGrantedSharesAvailableForGrant	-31782	shares
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P1Y
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	1.42	pure
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.59	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	93731	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	30498	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	14.69
CY2021	isig	Share Based Compensation Arrangement By Share Based Payment Award Number Of Granted Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfGrantedSharesAvailableForGrant	-5514	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2021	isig	Stock Options Exercised Plan Shares Available For Grant StockOptionsExercisedPlanSharesAvailableForGrant	0	shares
CY2021	isig	Stock Options Exercised Plan Options Outstanding StockOptionsExercisedPlanOptionsOutstanding	-1973	shares
CY2021	isig	Stock Options Exercised Weighted Average Exercise Per Share StockOptionsExercisedWeightedAverageExercisePerShare	13.59
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Vested SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested	17100	USD
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	97648	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	19122	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	13.23
CY2021Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	19122	shares
CY2021	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P4Y3M25D
CY2021Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	13.23
CY2021Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	15726	shares
CY2021Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	13.14
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	188322	USD
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	USD
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P3Y9M25D
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	156298	USD
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	21123	shares
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	44659	shares
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	12.16
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	31782	shares
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	6.00
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	22315	shares
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	11.36
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	4162	shares
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	10.30
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	49964	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	8.76
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	5514	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	8.16
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	40392	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	8.33
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	6555	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	9.28
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	8531	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	10.01
CY2021Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	5000	USD
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0.020	pure
CY2021Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions	30000	USD
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2020	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-233000	USD
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	42000	USD
CY2020	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	42000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	42000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-191000	USD
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210	pure
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0.008	pure
CY2020	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.036	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.036	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Tax Contingencies EffectiveIncomeTaxRateReconciliationTaxContingencies	-0.010	pure
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Tax Contingencies EffectiveIncomeTaxRateReconciliationTaxContingencies	-0.007	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.343	pure
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.196	pure
CY2021	isig	Effective Income Tax Rate Reconciliation Paycheck Protection Program Forgiveness EffectiveIncomeTaxRateReconciliationPaycheckProtectionProgramForgiveness	0.075	pure
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.008	pure
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.012	pure
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.043	pure
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	507000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	376000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	23000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	9000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	31000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	65000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	88000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	33000	USD
CY2021Q4	us-gaap	Liability For Uncertain Tax Positions Noncurrent LiabilityForUncertainTaxPositionsNoncurrent	711000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	2507000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	1422000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	33000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	47000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	33000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	52000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	3146000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	1946000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	76000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	58000	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities Prepaid Expenses DeferredTaxLiabilitiesPrepaidExpenses	76000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Prepaid Expenses DeferredTaxLiabilitiesPrepaidExpenses	58000	USD
CY2021Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	76000	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	58000	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	0	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	0	USD
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	1200000	USD
CY2020	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	943000	USD
CY2021Q4	us-gaap	Liability For Uncertain Tax Positions Noncurrent LiabilityForUncertainTaxPositionsNoncurrent	711000	USD
CY2020Q4	us-gaap	Liability For Uncertain Tax Positions Noncurrent LiabilityForUncertainTaxPositionsNoncurrent	677000	USD
CY2018Q4	us-gaap	Liability For Uncertain Tax Positions Noncurrent LiabilityForUncertainTaxPositionsNoncurrent	665000	USD
CY2019Q4	us-gaap	Liability For Uncertain Tax Positions Noncurrent LiabilityForUncertainTaxPositionsNoncurrent	643000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Expense UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense	-34000	USD
CY2020Q4	us-gaap	Liability For Uncertain Tax Positions Noncurrent LiabilityForUncertainTaxPositionsNoncurrent	677000	USD
CY2021	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Expense UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense	-34000	USD
CY2021	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Percent DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent	0.50	pure
CY2021	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	41000	USD
CY2020	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	62000	USD
CY2021Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	1054000	USD
CY2020Q2	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.0100	pure
CY2020Q2	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2022-04-22
CY2020Q2	isig	Number Of Monthly Payments Of Principal And Interest NumberOfMonthlyPaymentsOfPrincipalAndInterest	18	integer
CY2020Q2	isig	Paycheck Protection Program Loan Amount PaycheckProtectionProgramLoanAmount	1054000	USD
CY2021	us-gaap	Debt Instrument Increase Accrued Interest DebtInstrumentIncreaseAccruedInterest	8000	USD

Files In Submission

Name	View Source	Status
0001654954-22-002804-index-headers.html	Edgar Link	pending
0001654954-22-002804-index.html	Edgar Link	pending
0001654954-22-002804.txt	Edgar Link	pending
0001654954-22-002804-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
isig-20211231.xsd	Edgar Link	pending
isig-20211231_cal.xml	Edgar Link	unprocessable
isig-20211231_def.xml	Edgar Link	unprocessable
isig-20211231_lab.xml	Edgar Link	unprocessable
isig-20211231_pre.xml	Edgar Link	unprocessable
isig_10k.htm	Edgar Link	pending
isig_10k_htm.xml	Edgar Link	completed
isig_ex231.htm	Edgar Link	pending
isig_ex311.htm	Edgar Link	pending
isig_ex312.htm	Edgar Link	pending
isig_ex32.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$LDWY
LENDWAY, INC. Stock $ldwy

2021 Q4 Form 10-K Financial Statement

#000165495422002804 Filed on March 09, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LDWY LENDWAY, INC. Stock $ldwy

2021 Q4 Form 10-K Financial Statement

#000165495422002804 Filed on March 09, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LDWY
LENDWAY, INC. Stock $ldwy